Long-Term Care in Fontan Circulation: Surveillance and Management of Fontan-Associated Liver Disease and

Chaowapong Jarasvaraparn1, Gary R Schooler2, Iván A González3

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Indiana University, 705 Riley Hospital Drive, ROC 4210, Indianapolis, IN, 46202, USA. cjarasva@iu.edu.

Insights

Fontan-associated liver disease (FALD) and protein-losing enteropathy (PLE) are common after the Fontan procedure. Early recognition and multidisciplinary management are crucial for improving outcomes in these patients.

Area of Science:

  • Cardiology
  • Hepatology
  • Pediatric Gastroenterology

Background:

  • The Fontan procedure creates a unique physiology leading to chronic venous hypertension.
  • This venous hypertension results in multisystem injury, notably affecting the liver and gastrointestinal tract.

Purpose of the Study:

  • To review the clinical spectrum and management of Fontan-associated liver disease (FALD).
  • To examine protein-losing enteropathy (PLE) in the context of Fontan physiology.
  • To understand how chronic venous hypertension contributes to multisystem injury.

Main Methods:

  • Literature review of clinical studies and case reports.
  • Analysis of current understanding of Fontan circulation pathophysiology.
  • Synthesis of management strategies for FALD and PLE.

Main Results:

  • Liver fibrosis is a nearly universal complication, with cirrhosis affecting 43% by 30 years post-Fontan.
  • Standard biomarkers and imaging may underestimate FALD severity due to hepatic congestion.
  • Liver biopsy is the gold standard for staging FALD.
  • PLE results from multifactorial gastrointestinal protein loss.
  • A multidisciplinary approach is essential, especially for combined heart-liver transplantation in advanced cases.

Conclusions:

  • Fontan-associated liver disease (FALD) and protein-losing enteropathy (PLE) are inevitable consequences of Fontan physiology.
  • Standard diagnostic tools may be insufficient for accurate FALD staging.
  • Future research needs standardized staging and targeted therapies for lymphatic dysfunction and fibrosis progression.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...